Quantum Biopharma (QNTM) EV to FCF (2020 - 2026)

Quantum Biopharma has disclosed EV to FCF across 7 years of filings, most recently posting 18.48 for Q2 2026.

• In Q2 2026, EV to FCF rose 53.16% year-over-year to 18.48; the TTM figure through Jun 2026 stood at 45.55 (down 6.12% YoY), while the FY2025 annual figure was 9.47, down 162.01% from the prior year.
• EV to FCF came in at 18.48 for Q2 2026 at Quantum Biopharma, down from 9.6 in the prior quarter.
• In the past five years, EV to FCF ranged from a high of 379.5 in Q1 2022 to a low of 818.87 in Q1 2023.
• Average EV to FCF over 5 years is 105.79, with a median of 22.53 recorded in 2025.
• Year-over-year, EV to FCF slumped 355.43% in 2023 and jumped 446.89% in 2026.
• Over 5 years, EV to FCF stood at 38.89 in 2022, then tumbled by 355.43% to 177.13 in 2023, then surged by 126.71% to 47.31 in 2024, then sank by 156.19% to 26.58 in 2025, then surged by 30.47% to 18.48 in 2026.
• Per Business Quant data, the three most recent EV to FCF figures were 18.48 in Q2 2026, 9.6 in Q1 2026, and 26.58 in Q3 2025.